Suppr超能文献

与牛精核糖核酸酶和胰腺核糖核酸酶相比,血管生成素的免疫抑制活性。

Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease.

作者信息

Matousek J, Soucek J, Ríha J, Zankel T R, Benner S A

机构信息

Institute of Animal Physiology and Genetics, Academy of Sciences of Czech Republic, Libĕchov, Czech Republic.

出版信息

Comp Biochem Physiol B Biochem Mol Biol. 1995 Oct;112(2):235-41. doi: 10.1016/0305-0491(95)00075-5.

Abstract

Angiogenin, a member of the pancreatic-like ribonuclease family with a special biological action (RISBAses), is a basic protein that induces blood vessel formation. Another member of these special ribonucleases, bovine seminal ribonuclease (BS RNase), displays biological properties, including aspermatogenic, embryotoxic, antitumor and immunosuppressive activities. The effects of two angiogenin preparations tested on the biological activities mentioned above are reported and compared with those of BS RNase and RNase A. In contrast to RNase A, which was ineffective in all biological activities tested, angiogenin suppressed significantly the proliferation of human lymphocytes stimulated by phytohemagglutinin or concanavalin A or by allogenic human lymphocytes (mixed lymphocyte culture). However, angiogenin did not affect the growth of human tumor cell lines, development of cow and mouse embryos and spermatogenicity in mice. On the basis of these results, angiogenin is the first monomeric ribonuclease described so far that displays immunosuppressive activity similar to that of the dimeric BS RNase. The immunosuppressive activity of angiogenin might synergize with the effect on neovascularization of tumor tissues and thus contribute to the development of tumor.

摘要

血管生成素是具有特殊生物学作用的胰样核糖核酸酶家族(RISBAses)的成员之一,是一种诱导血管形成的碱性蛋白质。这些特殊核糖核酸酶的另一个成员,牛精浆核糖核酸酶(BS RNase),具有包括抗精子生成、胚胎毒性、抗肿瘤和免疫抑制活性在内的生物学特性。本文报道了所测试的两种血管生成素制剂对上述生物学活性的影响,并与BS RNase和RNase A的影响进行了比较。与在所有测试的生物学活性中均无效的RNase A不同,血管生成素显著抑制了由植物血凝素或伴刀豆球蛋白A刺激的人淋巴细胞或同种异体人淋巴细胞(混合淋巴细胞培养)的增殖。然而,血管生成素并不影响人肿瘤细胞系的生长、牛和小鼠胚胎的发育以及小鼠的精子生成能力。基于这些结果,血管生成素是迄今为止所描述的第一种显示出与二聚体BS RNase相似的免疫抑制活性的单体核糖核酸酶。血管生成素的免疫抑制活性可能与对肿瘤组织新血管形成的作用协同,从而促进肿瘤的发展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验